84 |
September 10, 2010 |
Asensio.com Releases Report on NASDAQ Official’s Questionable Dealings.
|
83 |
September 10, 2010 |
Another NASDAQ Official in China Discovered to Have Questionable Ties to NASDAQ-Listed Chinese Reverse Mergers.
|
82 |
March 12, 2010 |
Another NASDAQ Bell-Ringing Controversy: YUII
|
81 |
January 7, 2010 |
CSKI Erroneously Touts Its “High Ethical Standards” while NASDAQ Continues Its Supposed Listing Review.
|
80 |
December 30, 2009 |
As NASDAQ pursues its “just list them” policy China’s “huge fraud” makes headlines.
|
79 |
December 22, 2009 |
Bodisen and Wey’s Connections to NASDAQ’s Chinese Reverse Merger Mill Exposed.
|
78 |
December 22, 2009 |
NASDAQ’s Conflicts in Pegasus and Xu Raise Questions About Its Regulatory Reliability.
|
77 |
December 22, 2009 |
Top Chinese NASDAQ Official’s Resignation Raises Questions about NASDAQ’s Disclosures.
|
76 |
September 29, 2009 |
AIG’s Equity Value Fixed at $0.001 Per Share.
|
75 |
May 15, 2009 |
Manuel P. Asensio’s Comment on Timminco on Canada’s Business News Network.
|
74 |
October 14, 2008 |
Timminco news articles archive.
|
73 |
May 14, 2008 |
asensio.com Timminco reports archive.
|
72 |
April 1, 2008 |
asensio.com on Canada’s highest rated business news show.
|
71 |
April 26, 2006 |
Exactly Who is Chairman Cox Protecting?
|
70 |
February 6, 2005 |
Alaska’s Attorney General Renkes forced to resign over KFx dealings.
|
69 |
February 2, 2005 |
Renkes’ testimony labeled unconvincing and questionable.
|
68 |
January 25, 2005 |
Alaskans well prepared to review Bundy’s Renkes report.
|
67 |
January 18, 2005 |
Alaska Attorney General must be held accountable for role in KFx promotion.
|
66 |
January 11, 2005 |
Former U. S. Attorney finds Renkes’ KFx dealings violated code.
|
65 |
December 7, 2004 |
Former U.S. Attorney calls Renkes “totally unfit”.
|
64 |
November 1, 2004 |
Renkes “the-broker-did-it” cover-up comes under attack.
|
63 |
October 28, 2004 |
Governor places limits to Renkes investigation.
|
62 |
October 27, 2004 |
Anchorage Daily News: Renkes works on vow to sell KFx stock, donate profits
|
61 |
October 27, 2004 |
KFx being drawn into Alaska investigation.
|
60 |
October 20, 2004 |
KFx haunts Renkes.
|
59 |
October 5, 2004 |
Renkes refuses to take questions at press conference.
|
58 |
October 4, 2004 |
Renkes now tied to Jefferies and Kanturk.
|
57 |
October 1, 2004 |
Renkes throws KFx overboard in attempt to save himself.
|
56 |
September 30, 2004 |
Alaska’s Attorney General caught in KFx’s web.
|
55 |
September 30, 2004 |
Alaska Attorney General’s compromising dealings uncovered.
|
54 |
September 30, 2004 |
Attorney General’s foolish KFx dealings violate fair public policy.
|
53 |
May 3, 2002 |
Hemispherx continues to attempt to renew its over 13-year-old fraudulent AIDS promotion.
|
52 |
February 22, 2002 |
Hemispherx’s questionable defamation case under jury deliberation.
|
51 |
February 22, 2002 |
Jury finds Asensio did not defame Hemispherx.
|
50 |
February 2, 2002 |
New letter to Congress on significance of Hemispherx’s corporate irresponsibility.
|
49 |
January 28, 2002 |
NASD’s AMEX censured, floor chief barred and Chairman resigns as a result of the GAO’s investigation of its harassment of Asensio & Company, Inc.
|
48 |
January 28, 2002 |
AMEX failure leads to congressional investigation.
|
47 |
December 18, 2001 |
Even Carter’s co-conspirator objects to smallpox claims.
|
46 |
December 18, 2001 |
Hemispherx grossly misrepresents AHRQ report.
|
45 |
December 18, 2001 |
AMEX failed to close down Hemispherx’s warrant fraud.
|
44 |
December 18, 2001 |
HEB uses anti-terrorism scam in latest AMEX pump and dump operation, reports Asensio & Company.
|
43 |
November 21, 2001 |
Even Carter’s co-conspirator objects to latest scam.
|
42 |
October 2, 2001 |
AMEX’s Hemispherx stock fraud exceeds 30 million shares.
|
41 |
September 25, 2001 |
Ampligen and its clinical trials found flawed and useless, reports Asensio & Company, Inc.
|
40 |
February 8, 2001 |
Hemispherx issues yet another false and fraudulent release.
|
39 |
July 26, 2000 |
FDA charges Hemispherx with false and misleading Ampligen promote.
|
38 |
July 25, 2000 |
Hemispherx cited in three criminal indictments.
|
37 |
June 8, 2000 |
Asensio wins against Hemispherx.
|
36 |
June 1, 2000 |
KPMG terminates its five-year audit relationship with Hemispherx.
|
35 |
April 19, 2000 |
Hemispherx’s forced to make damning admissions.
|
34 |
March 17, 2000 |
Hemispherx charged with deception by AIDS organization. UCI denies having received Hemispherx’s alleged research grants.
|
33 |
August 10, 1999 |
Hemispherx continues attempts to control its stock trading.
|
32 |
August 10, 1999 |
Letter to FDA regarding Hemispherx cost recovery.
|
31 |
July 29, 1999 |
Yet another fraudulent stock promoter tied to Hemispherx.
|
30 |
July 14, 1999 |
Hemispherx fabricates false quotes from CFIDS Network.
|
29 |
July 13, 1999 |
Hemispherx’s Dr. Carter tied to “advocacy group” promotion of Ampligen despite FDA violation notice and restriction.
|
28 |
May 21, 1999 |
Hemispherx officers tied to other manipulated stocks.
|
27 |
May 13, 1999 |
AMEX fails to commence enforcement action against Hemispherx.
|
26 |
May 13, 1999 |
Compilation of Hemispherx’s false and fraudulent investor representations.
|
25 |
May 11, 1999 |
Hemispherx analyst makes false Ampligen HIV efficacy claims despite failed test and FDA violation notice.
|
24 |
March 18, 1999 |
Hemispherx Suffers Major Loss in Federal Court.
|
23 |
December 8, 1998 |
Leading researchers find CFS to be psychosomatic.
|
22 |
November 18, 1998 |
Hemispherx report reveals insider “pump and dump” operation.
|
21 |
October 28, 1998 |
Hemispherx issues false and exaggerated CFS prevalence rates.
|
20 |
October 28, 1998 |
Hemispherx’s CFS prevalence disclosures proven false.
|
19 |
October 28, 1998 |
Hemispherx confirms failure to disclose FDA violation.
|
18 |
October 27, 1998 |
FDA determines Hemispherx’s Ampligen claims violate regulations.
|
17 |
October 27, 1998 |
Hemispherx issues blatantly false FDA infraction statement.
|
16 |
October 14, 1998 |
Hemispherx’s hubris expands to legal profession.
|
15 |
October 14, 1998 |
Hemispherx CFS Phase III and orphan approvals found to be six years old.
|
14 |
October 13, 1998 |
Ampligen Safety Profile.
|
13 |
October 12, 1998 |
Hemispherx’s CFS conference presentations widely ignored.
|
12 |
October 8, 1998 |
Hemispherx distributes fraudulent Oprah Winfrey videotape.
|
11 |
October 1, 1998 |
Dr. Carter’s DuPont and Stratton-Oakmont assertions show intent to defraud.
|
10 |
October 1, 1998 |
Asensio & Company denies all charges in Hemispherx’s press release.
|
9 |
October 1, 1998 |
Hemispherx exposed to FDA sanctions.
|
8 |
September 30, 1998 |
Hemispherx attempts to prevent stock sale.
|
7 |
September 30, 1998 |
Hemispherx attempts to use false CFS prevalence rate in attempt to defraud investors.
|
6 |
September 30, 1998 |
Letter to FDA concerning Hemispherx violation of FDA regulations.
|
5 |
September 30, 1998 |
Hemispherx continues fraudulent stock promotion.
|
4 |
September 24, 1998 |
Hemispherx Announces Deal with Convicted Former-NCI Researcher.
|
3 |
September 22, 1998 |
Hemispherx’s Ampligen has no medical or economic value.
|
2 |
September 22, 1998 |
Asensio & Company, Inc. releases research report on Hemispherx Biopharma.
|
1 |
September 22, 1998 |
STRONG SELL RECOMMENDATION
|